Cost-Effectiveness and Heterogeneity: Using Finite Mixtures of Disease Activity Models to Identify and Analyze Phenotypes

Sixten Borg, Ulf-G. Gerdtham, Tobias Rydén, Pia Munkholm, Selwyn Odes, Bjørn Moum, Reinhold Stockbrügger and Stefan Lindgren
Additional contact information
Tobias Rydén: Department of Information Technology, Uppsala University, Postal: Department of Information Technology, Uppsala University, Sweden
Pia Munkholm: Department of Gastroenterology, North Zealand University Hospital, Postal: Department of Gastroenterology, Medical Section, Capital Region of Copenhagen, North Zealand University Hospital, Denmark
Selwyn Odes: Faculty of Health Sciences, Ben-Gurion University of the Negev, Postal: Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel
Bjørn Moum: University of Oslo, Institute of Clinical Medicine, Postal: University of Oslo, Institute of Clinical Medicine, Oslo, Norway
Reinhold Stockbrügger: Department of Gastroenterology and Hepatology, University Hospital Maastricht, Postal: Department of Gastroenterology and Hepatology, University Hospital Maastricht, Maastricht, Netherlands
Stefan Lindgren: Department of Clinical Sciences Malmö, Lund University, Postal: Department of Clinical Sciences Malmö, Lund University

No 2015:5, Working Papers from Lund University, Department of Economics

Abstract: Heterogeneity in patient populations is an important issue in health economic evaluations, as the cost-effectiveness of an intervention can vary between patient subgroups, and an intervention which is not cost-effective in the overall population may be cost-effective in particular subgroups. Identifying such subgroups is of interest in the allocation of healthcare resources. Our aim was to develop a method for cost-effectiveness analysis in heterogeneous chronic diseases, by identifying subgroups (phenotypes) directly relevant to the cost-effectiveness of an intervention, and by enabling cost-effectiveness analyses of the intervention in each of these phenotypes. We identified phenotypes based on healthcare resource utilization, using finite mixtures of underlying disease activity models: first, an explicit disease activity model, and secondly, a model of aggregated disease activity. They differed with regards to time-dependence, level of detail, and what interventions they could evaluate. We used them for cost-effectiveness analyses of two hypothetical interventions. Allowing for different phenotypes improved model fit, and was a key step towards dealing with heterogeneity. The cost-effectiveness of the interventions varied substantially between phenotypes. Using underlying disease activity models for identifying phenotypes as well as cost-effectiveness analysis appears both feasible and useful in that they guide the decision to introduce an intervention.

Keywords: Cost-effectiveness; Disease heterogeneity; Phenotypes; Latent classes; Disease activity model; Crohn's disease (search for similar items in EconPapers)
JEL-codes: C18 D70 (search for similar items in EconPapers)
Pages: 25 pages
Date: 2015-02-06
New Economics Papers: this item is included in nep-hea
References: Add references at CitEc
Citations:

Downloads: (external link)
http://project.nek.lu.se/publications/workpap/papers/wp15_5.pdf (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:hhs:lunewp:2015_005

Access Statistics for this paper

More papers in Working Papers from Lund University, Department of Economics School of Economics and Management, Box 7080, S-22007 Lund, Sweden. Contact information at EDIRC.
Bibliographic data for series maintained by Iker Arregui Alegria ().